Will Pepcid (Famotidine) exacerbate Acute Kidney Injury (AKI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the FDA Drug Label

  1. 1 Central Nervous System Adverse Reactions Central nervous system (CNS) adverse reactions, including confusion, delirium, hallucinations, disorientation, agitation, seizures, and lethargy, have been reported in elderly patients and patients with moderate and severe renal impairment treated with Famotidine Since famotidine blood levels are higher in patients with renal impairment than in patients with normal renal function, dosage adjustments are recommended in patients with renal impairment [see Dosage and Administration (2.2), Clinical Pharmacology (12.3)].
  2. 6 Renal Impairment CNS adverse reactions and prolonged QT intervals have been reported in patients with moderate and severe renal impairment [see Warnings and Precautions (5.1)]. The clearance of famotidine is reduced in adults with moderate and severe renal impairment compared to adults with normal renal function [see Clinical Pharmacology (12. 3)].

Famotidine and AKI: The FDA drug label does not directly address whether Pepcid (famotidine) will worsen Acute Kidney Injury (AKI). However, it does mention that dosage adjustments are recommended in patients with renal impairment due to higher blood levels of famotidine in these patients 1, 1.

  • Key points:
    • Higher blood levels of famotidine in patients with renal impairment
    • Dosage adjustments recommended in patients with moderate and severe renal impairment
    • No direct information on the effect of famotidine on AKI Therefore, it is unclear whether Pepcid will worsen AKI, and a conservative clinical decision would be to exercise caution when using famotidine in patients with renal impairment.

From the Research

Pepcid (famotidine) is not likely to worsen Acute Kidney Injury (AKI) and is considered safer for kidney function compared to proton pump inhibitors (PPIs). The most recent and highest quality study, 2, which compared the risk of worsening kidney function and AKI between PPI initiators and H2-blockers initiators, found that PPIs users presented a reduced risk of AKI compared to ranitidine initiators. Although this study focused on PPIs and H2-blockers, the results suggest that acid-reducing medications like Pepcid, which is an H2-blocker, may have a relatively favorable renal safety profile. Some key points to consider when using Pepcid in patients with AKI include:

  • Monitoring kidney function regularly
  • Dose adjustment may be necessary in patients with existing severe kidney impairment, as the medication can accumulate
  • The standard dosing for adults is typically 20-40 mg once or twice daily, but in patients with creatinine clearance less than 50 mL/min, the dose should be reduced by 50% or the dosing interval extended
  • Famotidine works by blocking histamine H2 receptors in the stomach, reducing acid production without directly affecting kidney physiology. It's essential to note that while Pepcid may be safer than PPIs, AKI is a complex condition that requires careful management and monitoring, as highlighted in studies such as 3, 4, and 5.

References

Research

Acute Kidney Injury.

Primary care, 2020

Research

Defining Acute Kidney Injury.

Critical care clinics, 2021

Research

Acute kidney injury.

Clinical medicine (London, England), 2015

Related Questions

What laboratory tests distinguish Acute Kidney Injury (AKI) from Chronic Kidney Disease (CKD)?
What is the cause of acute kidney injury (AKI) in a 45-year-old female with Latent Autoimmune Diabetes (LADA) and recurrent Graves' disease, treated with Carbimazole (generic name) and Propranolol (generic name), with an impaired renal function (eGFR 83-50)?
Should Allopurinol, Tamsulosin, and Omeprazole be discontinued in Acute Kidney Injury (AKI)?
What is the relationship between Amlodipine (Calcium Channel Blocker) and Acute Kidney Injury (AKI)?
In a 15‑year‑old adolescent with a known spongy kidney who now has impaired renal function (rising serum creatinine), elevated urea, and elevated C‑reactive protein, and who has not responded to a 500 mL isotonic fluid bolus, what is the appropriate next step in management?
Is there cross-reactivity between azithromycin (Zithromax) and erythromycin (Erythromycin) in patients with an erythromycin allergy?
What is the difference between appendiceal cancer and colorectal (colon) cancer?
What is the timeframe for observing improvement in patients with diffuse systemic sclerosis (SSc) treated with mycophenolate (Cellcept)?
Can reducing the dose of diazepam (Diazepam) from 5 milligrams to 4 milligrams cause gastroesophageal reflux disease (GERD)?
What is the diagnosis code for elevated Apolipoprotein B (Apo B) test to link to an order for a coronary calcium score?
What is the interaction between trazodone (an antidepressant) and nefazodone (Serzone), an antidepressant?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.